🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 75% of ingredients have research evidence
A Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Tablet(s) Serving Size
Mineral Product Type
75% Evidence Coverage

Supplement Facts — Evidence Check

10 mg (1% DV)
📊 Market median: 99.0mg (503 products) 📚 12 studies (Tier A: 0, B: 3)
RDA 700mg This product: 10mg UL 4000mg
75 mcg (50% DV)
✅ Within RDA (0.5× RDA of 0.15 mg) 📚 243 studies (Tier A: 4, B: 133)
RDA 0.15mg This product: 0.075mg UL 1.1mg
4 mg (27% DV)
✅ Within RDA (0.4× RDA of 11 mg) 📚 258 studies (Tier A: 6, B: 134)
RDA 11mg This product: 4mg UL 40mg
0.275 mcg
📊 Market median: 0.2mg (343 products) 📚 172 studies (Tier A: 0, B: 67)
RDA 0.055mg This product: 0.000275mg UL 0.4mg
0.45 mg (23% DV)
✅ Within RDA (0.5× RDA of 0.9 mg) 📚 36 studies (Tier A: 0, B: 11)
RDA 0.9mg This product: 0.45mg UL 10mg
0.9 mg (45% DV)
✅ Within RDA (0.4× RDA of 2.3 mg) 📚 8 studies — no high-quality reviews
RDA 2.3mg This product: 0.9mg UL 11mg
13 mcg (11% DV)
✅ Within RDA (0.4× RDA of 0.035 mg) 📚 197 studies (Tier A: 1, B: 55)
RDA 0.035mg This product: 0.013mg
23 mcg (31% DV)
✅ Within RDA (0.5× RDA of 0.045 mg) 📚 2 studies — no high-quality reviews
RDA 0.045mg This product: 0.023mg UL 2mg

Other Ingredients

Dextrose Microcrystalline Cellulose Stearic Acid Silicon Dioxide

Label Claims — Verification

All Other
Structure/Function
All Other (98% of products) Structure/Function (89% of products) Nutrient (76% of products)

Target Groups

Adult (18 - 50 Years)

Product Information

📋 Directions for Use

Directions: Adults, take one tablet daily as a dietary supplement, preferably with a meal.

⚠️ Warnings & Precautions

FOIL - TAMPER RESISTANT SEAL If printed heat induced seal appears to be tampered with, do not use product.

Keep Out of the Reach of Children.

🧪 Formulation Notes

Balanced Minerals for Women & Men*

GUARANTEED NO ADDED: Yeast, soy, wheat, dairy, gluten, egg, fragrance.

Additional Information

Store in a dry, controlled room environment.

QUALITY GUARANTEED This product has been manufactured and packaged in strict conformance with industry and government standards.

Product #989007

MADE IN USA

Product Details

UPC / SKU 6 39277 89007 8
DSLD Entry Date 2012-12-21
Product Type Mineral
Form Tablet or Pill
DSLD ID 17070
Data Updated 2026-04-11

Research Evidence

46 Research Sources
55 Avg Quality Score
23 Meta Analysis
7 Systematic Review
7 Rct
4 Clinical Trial
2 Other
1 Guideline
1 Regulatory Source
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2018
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2025
B Phosphate binders for preventing and treating bone disease in chronic kidney disease patients
Meta Analysis The Cochrane database of systematic reviews 2011
B Calcium and phosphorus supplementation of human milk for preterm infants
Systematic Review The Cochrane database of systematic reviews 2017
B Radiographic and clinical outcomes of silicate-substituted calcium phosphate (SiCaP) bone grafts in spinal fusion: Systematic review and meta-analysis
Meta Analysis Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2020
B ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Calcium, phosphorus and magnesium.
Guideline Clinical nutrition (Edinburgh, Scotland) 2018
B Effect of different phosphate binders on fibroblast growth factor 23 levels in patients with chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials
Meta Analysis Annals of palliative medicine 2022
B Pyridoxal 5 phosphate for neuroleptic-induced tardive dyskinesia
Meta Analysis The Cochrane database of systematic reviews 2015
B The impact of phosphate lowering agents on clinical and laboratory outcomes in chronic kidney disease patients: a systematic review and meta-analysis of randomized controlled trials
Meta Analysis Journal of nephrology 2022
B Calcimimetics treatment strategy for serum calcium and phosphate management in patients with secondary hyperparathyroidism undergoing dialysis: A systematic review and meta-analysis of randomized studies
Meta Analysis Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2024
View all evidence for Phosphorus →

Compare Similar Products

View all Phosphorus products →